Meiyan Wei

Title: Meiyan Wei: Innovator in Antitumor Agents

Introduction

Meiyan Wei is a prominent inventor based in Qingdao, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have the potential to treat various types of cancer. With a total of 3 patents to her name, her work is paving the way for innovative treatments in oncology.

Latest Patents

One of her latest patents is focused on macrolide brefeldin A ester derivatives and their use in inhibiting tumor proliferation. These ester derivatives are represented by a specific formula and are notable for their effectiveness in preventing or treating hyperproliferative diseases, including various forms of cancer such as liver cancer, leukemia, and breast cancer. Another significant patent involves penicinotam derivatives, which include a range of chemical forms and their pharmaceutical compositions. These derivatives are aimed at treating diseases caused by inflammation and immune system disorders.

Career Highlights

Meiyan Wei is affiliated with the Ocean University of China, where she conducts her research and development work. Her innovative approach and dedication to her field have established her as a key figure in pharmaceutical research.

Collaborations

She collaborates with notable colleagues, including Changlun Shao and Yaoyao Jiang, who contribute to her research endeavors.

Conclusion

Meiyan Wei's contributions to the field of pharmaceuticals, particularly in the development of antitumor agents, highlight her role as an influential inventor. Her work continues to inspire advancements in cancer treatment and showcases the importance of innovation in healthcare.